相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Breast Implant-associated Anaplastic Large Cell Lymphoma A Prospective Series of 52 Patients
Sarah E. Tevis et al.
ANNALS OF SURGERY (2022)
Current Progress in Breast Implant-Associated Anaplastic Large Cell Lymphoma
Yichen Wang et al.
FRONTIERS IN ONCOLOGY (2022)
Breast Implant-associated Anaplastic Large Cell Lymphoma
Shaikha Alotaibi et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease
Mark G. Evans et al.
MODERN PATHOLOGY (2021)
Breast implant-associated anaplastic large cell lymphoma: A comprehensive review
Antonio Marra et al.
CANCER TREATMENT REVIEWS (2020)
Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants
Peter G. Cordeiro et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2020)
Characteristics and Treatment of Advanced Breast Implant-Associated Anaplastic Large Cell Lymphoma
Meredith S. Collins et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2019)
Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): Initial Report of Findings, 2012-2018
Colleen M. McCarthy et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2019)
Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma
Gregory A. Lamaris et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2019)
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
Steven Horwitz et al.
LANCET (2019)
Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma
Maria C. Ferrufino-Schmidt et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
NCCN Consensus Guidelines for the Diagnosis and Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma
Mark W. Clemens et al.
AESTHETIC SURGERY JOURNAL (2017)
Breast Implant-Associated Anaplastic Large Cell Lymphoma A Systematic Review
Ashley N. Leberfinger et al.
JAMA SURGERY (2017)
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma
Mark W. Clemens et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Skin involvement as the first manifestation of breast implant-associated anaplastic large cell lymphoma
Rebeca Alcala et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2016)
Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
Barbara Pro et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Anaplastic Large Cell Lymphoma and Breast Implants: A Systematic Review
Benjamin Kim et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2011)
Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas.
Anas Younes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)